Meat alternatives: plant-based or petri dish-based?
Faux meat could reach 9% share of the estimated $2.7-trillion global meat market by 2040, but lab-produced meat is gaining traction
18 September 2019 - 12:57
byTatiana Darie
Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
New York — The alternative meat market is poised to rise to $240bn over the next two decades as new technologies gain ground and consumers change their diets, according to investment banking company Jefferies.
The great “protein shake-up” could see faux meat reach 9% share of the estimated $2.7-trillion global meat market by 2040, analyst Simon Powell forecasts, from less than 1% now. The size of the plant-based meat market has been one of the biggest debates in the food industry recently, with estimates ranging from between $10bn and $40bn, to as high as $140bn.
Plant-based meats, such as those produced by Beyond Meat, are currently leading the category but lab-created “cellular” meat could overtake its plant-based counterpart, Powell said. “The cellular-based alternative industry has the potential to grow fast off a small base and could quickly start mass producing real meat if it can reduce costs and industrialise the current lab-based approach.”
Rising estimates for the faux-meat market are one way to justify the eye-popping valuations for its producers. Beyond Meat, for example, commands a valuation of $9.7bn, or 110 times its 2018 sales. Its closely-held peer, Impossible Foods, is valued at $1.52bn, with revenues estimated at $110m in 2018, according to data compiled by PrivCo.
Investments in lab-created meat companies have trailed their plant-based peers as commercial products have yet to emerge. Private cell-based meat firms received $50m in new investments in 2018, according to data compiled by Good Food Institute, compared to more than $500m for plant-based food producers.
While taste, costs and ingredients will ultimately differentiate the products, both categories stand to disrupt the large global meat market, Jefferies’ Powell said. Other catalysts for alternative meat’s rise includes a potential meat tax, now being discussed in some countries, and the pork crisis in China, he noted.
So far, existing products enjoy broad support from consumers, separate research by Bank of America shows. “There is strong interest and repeat purchase intent for plant-based proteins,” analysts led by Bryan Spillane wrote. “Established food companies will need to ramp product development and build brand authenticity to catch up to ‘Beyond’ and ‘Impossible’.”
Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
Meat alternatives: plant-based or petri dish-based?
Faux meat could reach 9% share of the estimated $2.7-trillion global meat market by 2040, but lab-produced meat is gaining traction
New York — The alternative meat market is poised to rise to $240bn over the next two decades as new technologies gain ground and consumers change their diets, according to investment banking company Jefferies.
The great “protein shake-up” could see faux meat reach 9% share of the estimated $2.7-trillion global meat market by 2040, analyst Simon Powell forecasts, from less than 1% now. The size of the plant-based meat market has been one of the biggest debates in the food industry recently, with estimates ranging from between $10bn and $40bn, to as high as $140bn.
Plant-based meats, such as those produced by Beyond Meat, are currently leading the category but lab-created “cellular” meat could overtake its plant-based counterpart, Powell said. “The cellular-based alternative industry has the potential to grow fast off a small base and could quickly start mass producing real meat if it can reduce costs and industrialise the current lab-based approach.”
Rising estimates for the faux-meat market are one way to justify the eye-popping valuations for its producers. Beyond Meat, for example, commands a valuation of $9.7bn, or 110 times its 2018 sales. Its closely-held peer, Impossible Foods, is valued at $1.52bn, with revenues estimated at $110m in 2018, according to data compiled by PrivCo.
Investments in lab-created meat companies have trailed their plant-based peers as commercial products have yet to emerge. Private cell-based meat firms received $50m in new investments in 2018, according to data compiled by Good Food Institute, compared to more than $500m for plant-based food producers.
While taste, costs and ingredients will ultimately differentiate the products, both categories stand to disrupt the large global meat market, Jefferies’ Powell said. Other catalysts for alternative meat’s rise includes a potential meat tax, now being discussed in some countries, and the pork crisis in China, he noted.
So far, existing products enjoy broad support from consumers, separate research by Bank of America shows. “There is strong interest and repeat purchase intent for plant-based proteins,” analysts led by Bryan Spillane wrote. “Established food companies will need to ramp product development and build brand authenticity to catch up to ‘Beyond’ and ‘Impossible’.”
Bloomberg
Lab-grown burgers have no shortage of funding for start-ups
Plant-based food sales gather momentum in the US
Oil companies more transparent about their emissions than meat and dairy firms
Heme burgers, but is the faux-meat ingredient safe?
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Most Read
Related Articles
KFC to put Beyond Meat’s chicken wings and nuggets to the test
Impossible Foods’ fake-meat Whopper in 7,000 Burger Kings
Bunge swings into profit on investment in Beyond Meat
A vegan America would be low on nutrients, but also low on greenhouse gases
Meat or methane — a menu choice for the future?
Published by Arena Holdings and distributed with the Financial Mail on the last Thursday of every month except December and January.